Julia German Cortes Research technician in the ''Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT'' group of the Vall d'Hebron Research Institute VHIR, working on the synthesis of polymeric and lipidic nanoparticles for drug delivery to treat different types of cancer and, specifically, against cancer stem cells (CSC). Instituciones de las que forman parte Técnico de investigación Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Julia German Cortes LinkedIn Twitter Orcid Instituciones de las que forman parte Técnico de investigación Bioquímica Clínica, Vehiculización de Fármacos y Terapia Vall Hebron Institut de Recerca Research technician in the ''Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT'' group of the Vall d'Hebron Research Institute VHIR, working on the synthesis of polymeric and lipidic nanoparticles for drug delivery to treat different types of cancer and, specifically, against cancer stem cells (CSC).
Graduated in Biomedical Sciences in 2021 from the Autonomous University of Barcelona (UAB) with an internship in the UAB group "Human host defense RNases". Master in Translational Biomedical Research from the Vall d'Hebron Research Institute (VHIR) in 2021-2022 which allowed me to do an internship in the Drug Delivery and Targeting (DDT) group of the VHIR working with gelatin nanoparticles for the treatment of cancer of ovary.
Proyectos SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.. IP: - Colaboradores: Marc Miquel Moltó Abad, Olga Sánchez- Maroto Carrizo, Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats, Angels Alcina Mila, Maria Fidel Lledò, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro Entidad financiadora: EUROPEAN COMMISSION Financiación: 649580 Referencia: SAFE-N-MEDTECHEC_H2020-NMBP2018 Duración: 01/04/2019 - 30/09/2023 Paginación Primera página « Página anterior ‹ Página 1 Página actual 2
